Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - RESEARCH & DEVELOPMENT
Research & Development DMAC - DiaMedica Therapeutics Inc.
13.1 M
LAST VALUE
22.30%
2 YEAR CAGR
23.72%
5 YEAR CAGR
13.24%
10 YEAR CAGR